Baidu
map

性激素六项检测报告,一文读懂!

2016-08-27 佚名 检验医学网

常常有患者拿着报告单询问医生:“医生,我的性激素六项都在正常范围内,为何备孕失败或月经不调呢?”也有不孕者说:“医生,你弄错了吧,我反复核对过,各项性激素指标都在正常范围内,你为何考虑我有多囊卵巢综合征?”更有不孕者不解地问:“我月经正常,除了备孕失败,凭什么说我卵巢储备功能下降?”当局者迷,旁观者清,这也正是性激素的神秘之处。在正常月经周期内,六项性激素有各自不同的分泌曲线,不同的检测时间,

常常有患者拿着报告单询问医生:“医生,我的性激素六项都在正常范围内,为何备孕失败或月经不调呢?”也有不孕者说:“医生,你弄错了吧,我反复核对过,各项性激素指标都在正常范围内,你为何考虑我有多囊卵巢综合征?”更有不孕者不解地问:“我月经正常,除了备孕失败,凭什么说我卵巢储备功能下降?”当局者迷,旁观者清,这也正是性激素的神秘之处


在正常月经周期内,六项性激素有各自不同的分泌曲线,不同的检测时间,会出现不同的检测结果,对每一项指标需要结合与其它激素的水平综合分析。




性激素检查项目


对于女性不孕者或者月经不调者,通常医生会开出的月经来潮第2-5天的性激素六项检查,包括垂体分泌的促性腺激素——卵泡刺激素(FSH)、黄体生成素(LH)、催乳激素(PRL),卵巢分泌的性激素——雌激素(E)、孕激素(P)、雄激素(T)。通过检测这些血清的激素水平,可了解女性的卵巢基础功能,并对生殖内分泌疾病进行诊断。


性激素检查时间




检查内分泌最好在月经来潮的第2-3天,这一段时间属于卵泡早期,可以反应卵巢的功能状态。但对于月经长期不来潮而且又急于了解检查结果者,则随时可以检查。


查基础性激素前至少一个月不能用性激素类药物,包括黄体酮、雌激素类及避孕药类,否则结果不靠谱,当然治疗后需要复查性激素者除外。


确定是来月经第3-5天,检查性激素5项即可,可以不查孕酮,孕酮应该在黄体期检查(月经21天或排卵后7天);但不能肯定阴道流血是否月经,应该检查6项,根据孕酮P数据可以大概判断月经周期时段。


性激素检查的临床意义


卵泡刺激素(FSH)和黄体生成素(LH)


1,卵巢功能衰竭:基础FSH﹥40IU/L、LH升高或﹥40IU/L,为高促性腺激素(Gn)闭经,即卵巢功能衰竭;如发生于40岁以前,称为卵巢早衰(POF)。


2,基础FSH和LH均﹤5IU/L 为低 Gn 闭经,提示下丘脑或垂体功能减退,而二者的区别需借助促性腺激素释放激素(GnRH)试验。


3,卵巢储备功能不良(DOR):基础FSH/LH﹥2-3.6提示DOR(FSH可以在正常范围),是卵巢功能不良的早期表现;基础FSH﹥12IU/L,下周期复查,连续﹥12IU/L提示DOR。


4,多囊卵巢综合征(PCOS):基础LH/FSH﹥2-3,可作为诊断PCOS的主要指标(基础LH水平﹥10IU/L即为升高,或LH维持正常水平,而基础FSH相对低水平,就形成了LH与FSH比值升高)。


5,检查2次基础FSH>20IU/L,可认为是卵巢早衰隐匿期,提示1年后可能闭经。


雌二醇(E2)


雌二醇:由卵巢的卵泡分泌,主要功能是促使子宫内膜增殖,促进女性生理活动。


1,提示生育能力下降:基础雌二醇E2>165.2-293.6pmol/L(45-80pg/mL),无论年龄与FSH如何,均提示生育力下降。基础E2≥367pmol/L(100pg/mL)时,卵巢反应更差,即使FSH﹤15IU/L,也基本无妊娠可能。


2,提示卵巢早衰:基础雌二醇E2水平<73.2 pmol/L,提示卵巢早衰(premature ovarian failure,POF)。


3、监测卵泡成熟和卵巢过度刺激综合征(OHSS)的指标


4,诊断有无排卵:无排卵时激素无周期性变化,常见于无排卵性功能失调性子宫出血、多囊卵巢综合征、某些绝经后出血。


5,诊断女性性早熟:临床多以 8 岁之前出现第二性征发育诊断性早熟,血 E2水平升高>275pmol/L 为诊断性早熟的激素指标之一。


催乳激素(PRL)


催乳素是由垂体前叶的泌乳滋养细胞分泌的蛋白质激素,在非哺乳期,女性PRL正常值为:5.18-26.53 ng/ml。


PRL水平随月经周期波动较小,但具有与睡眠相关的节律性,入睡短期内分泌增加,醒后PRL下降,下午较上午升高,餐后较餐前升高。根据这种节律分泌特点,大约上午9-10点是其分泌的低谷,应在此时空腹抽血。PRL的分泌受多种因素的影响,例如饱食、寒冷、性交、情绪波动、刺激乳房等均会导致PRL升高。


一次检测值偏高不足以诊断为高催乳素血症,需排除以上影响因素后重复测1-2次,连续两次高于正常范围方可诊断。


PRL≥25ng/ml或高于实验室设的正常值为高催乳素血症,但须需排除怀孕、药物及甲状腺机能减退的影响。PRL﹥50ng/ml者,约20%有垂体泌乳素瘤;PRL﹥100ng/ml者,约50%有泌乳素瘤,可行垂体CT或磁共振检查;PRL降低见于席汉综合征、使用抗PRL药物。


PRL水平升高还见于性早熟、原发性甲状腺功能减低、卵巢早衰、黄体功能欠佳、长期哺乳、神经精神刺激(如氯丙嗪、避孕药、大量雌激素、利血平等)。10%-15%多囊卵巢综合征患者表现为轻度的高泌乳素血症,其可能为雌激素持续刺激所致。


PRL降低:垂体功能减退、单纯性催乳素分娩缺乏,使用抗PRL药物等。


睾酮(T)


雄激素由卵巢及肾上腺皮质分泌。雄激素分为睾酮和雄烯二酮。99%以上的睾酮在血循环中与性激素结合球蛋白(SHBG)结合,呈无活性状态。只有1%的游离T有生物活性。胰岛素抵抗的代谢紊乱者,SHBG水平下降,游离T升高,在总T并不升高的情况下,出现高雄激素血症的表现。


1,卵巢男性化肿瘤:女性短期内出现进行性加重的雄激素过多症状及血清雄激素升高往往提示卵巢男性化肿瘤。


2,多囊卵巢综合征:睾酮水平通常不超过正常范围上限2倍,雄烯二酮常升高,脱氢表雄酮正常或轻度升高。若治疗前雄激素水平升高,治疗后应下降,故血清雄激素水平可作为评价疗效指标之一。多囊卵巢综合征患者,血T值呈轻度到中度升高,这既是长期不排卵的结果,又是进一步影响排卵的原因。


3,肾上腺皮质增生肿瘤血清雄激素异常升高,睾酮水平升高超过正常值上界2倍以上者,应首先排除卵巢或肾上腺有分泌雄激素的肿瘤。


4,两性畸形:男性假两性畸形及真两性畸形,睾酮水平在男性正常值范围内;女性假两性畸形在女性正常值范围内。


5,女性多毛症:测血清睾酮水平正常时,多系毛囊对雄激素敏感所致。


6,高催乳素血症:女性有雄激素过多症状和体征,但雄激素水平在正常范围者,应测定血清催乳素水平。


孕酮(P)


1,判断排卵:黄体中期(月经周期28日的妇女为月经第21日)P>15.9nmol/L 提示排卵。使用促排卵药物时,可用血孕酮水平观察促排卵效果。


2,诊断黄体功能不全(LPD):黄体期血孕酮水平低于生理值,提示黄体功能不足、排卵型子宫功能失调性出血。


3,判断体外受精-胚胎移植(IVF-ET)预后:排卵前P水平可以估计IVF-ET预后。肌注hCG日P≥3.18nmol/L(1.0ng/mL) 应视为升高,种植率及临床妊娠率均下降,P﹥4.77nmol/L(1.5ng/mL)提示过早黄素化。


4,鉴别异位妊娠:异位妊娠血P水平偏低,多数患者血P﹤47.7nmol/L(15ng/mL)。仅有1.5%的患者≥79.5nmol/L(25ng/mL)。正常宫内妊娠者的P 90%﹥78nmol/L。血P水平在宫内与宫外孕的鉴别诊断中,可以作为参考依据。


5,辅助诊断先兆流产:孕12周内,孕酮水平低,早期流产风险高。先兆流产时,孕酮值若有下降趋势有可能流产。


6,观察胎盘功能:妊娠期胎盘功能减退时,血中孕酮水平下降。单次血清孕酮水平P≤15.6nmol/L(5ng/mL),提示为死胎。


除上述经典的性激素六项之外,血清抗苗勒管激素(AMH)是近年来认为评价卵巢衰老的较佳的内分泌学指标,AMH水平与获卵数及卵巢反应性呈正相关,可以作为预测卵巢储备功能及促排卵过程中卵巢反应性的血清学标记物。


抗苗勒管激素(AMH)


抗苗勒管激素(AMH)又称为苗勒管抑制物质,不受下丘脑-垂体-卵巢轴的调控,在月经周期中无周期性变化,水平恒定,可在月经周期中任一天抽血检测(0.5-1.1ng/ml)。

AMH可较FSH、雌二醇、LH、InhB等更早地反映原始卵泡池中的卵泡数量,更早期、准确地反映卵巢功能状态。研究发现多囊卵巢综合征PCOS患者血清和卵泡液AMH水平升高,高水平AMH可能造成了PCOS卵泡生长和排卵异常。


卵巢储备功能正常者:1.0-1.4mg/L<抗苗勒管激素(AMH)<3.5-4.0mg/L。


专家提示:


对于妇科和生殖专科医生来说,掌握性激素在正常月经周期的分泌规律,时间节律特征,才能更好地解读性激素检查报告。


生殖内分泌疾病的诊断须参考几项激素水平,并结合病史和辅助检查综合分析。原则上除了疑似卵巢功能减退外,对于大多不孕者来说无需反复检测血清激素水平,在用药前的那次基础检测最为重要。患者可以带齐化验报告及病历资料,请生殖中心的医生帮助分析激素检测结果。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=206964, encodeId=d74420696435, content=很详细,又明白。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e5d2054796, createdName=1591ec95f6m, createdTime=Mon Jun 05 22:02:46 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182675, encodeId=a74e1826e582, content=很实用,请问达芙通对性激素的结果影响大吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e9a1831510, createdName=ms1301173364092757, createdTime=Sat Mar 25 19:10:09 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642531, encodeId=f0ad164253127, content=<a href='/topic/show?id=d13f526846e' target=_blank style='color:#2F92EE;'>#性激素六项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52684, encryptionId=d13f526846e, topicName=性激素六项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f6622955739, createdName=12498e67m35暂无昵称, createdTime=Mon Feb 27 12:51:00 CST 2017, time=2017-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=109236, encodeId=4baa109236eb, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 23:51:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=108784, encodeId=1d78108e84df, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 09:39:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106531, encodeId=f91e106531f1, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Aug 29 05:17:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286362, encodeId=caee1286362ac, content=<a href='/topic/show?id=24395268347' target=_blank style='color:#2F92EE;'>#性激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52683, encryptionId=24395268347, topicName=性激素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Mon Aug 29 03:51:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106456, encodeId=a3c0106456e9, content=学习了,慢慢消化, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160616/IMG5762A3665DC7B3997.jpg, createdBy=df0a1649089, createdName=ys2323, createdTime=Sun Aug 28 22:38:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106033, encodeId=1c081060334d, content=很全面,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sun Aug 28 01:15:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106010, encodeId=c18f10601032, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 27 23:31:00 CST 2016, time=2016-08-27, status=1, ipAttribution=)]
    2017-06-05 1591ec95f6m

    很详细,又明白。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=206964, encodeId=d74420696435, content=很详细,又明白。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e5d2054796, createdName=1591ec95f6m, createdTime=Mon Jun 05 22:02:46 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182675, encodeId=a74e1826e582, content=很实用,请问达芙通对性激素的结果影响大吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e9a1831510, createdName=ms1301173364092757, createdTime=Sat Mar 25 19:10:09 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642531, encodeId=f0ad164253127, content=<a href='/topic/show?id=d13f526846e' target=_blank style='color:#2F92EE;'>#性激素六项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52684, encryptionId=d13f526846e, topicName=性激素六项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f6622955739, createdName=12498e67m35暂无昵称, createdTime=Mon Feb 27 12:51:00 CST 2017, time=2017-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=109236, encodeId=4baa109236eb, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 23:51:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=108784, encodeId=1d78108e84df, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 09:39:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106531, encodeId=f91e106531f1, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Aug 29 05:17:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286362, encodeId=caee1286362ac, content=<a href='/topic/show?id=24395268347' target=_blank style='color:#2F92EE;'>#性激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52683, encryptionId=24395268347, topicName=性激素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Mon Aug 29 03:51:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106456, encodeId=a3c0106456e9, content=学习了,慢慢消化, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160616/IMG5762A3665DC7B3997.jpg, createdBy=df0a1649089, createdName=ys2323, createdTime=Sun Aug 28 22:38:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106033, encodeId=1c081060334d, content=很全面,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sun Aug 28 01:15:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106010, encodeId=c18f10601032, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 27 23:31:00 CST 2016, time=2016-08-27, status=1, ipAttribution=)]
    2017-03-25 ms1301173364092757

    很实用,请问达芙通对性激素的结果影响大吗?

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=206964, encodeId=d74420696435, content=很详细,又明白。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e5d2054796, createdName=1591ec95f6m, createdTime=Mon Jun 05 22:02:46 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182675, encodeId=a74e1826e582, content=很实用,请问达芙通对性激素的结果影响大吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e9a1831510, createdName=ms1301173364092757, createdTime=Sat Mar 25 19:10:09 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642531, encodeId=f0ad164253127, content=<a href='/topic/show?id=d13f526846e' target=_blank style='color:#2F92EE;'>#性激素六项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52684, encryptionId=d13f526846e, topicName=性激素六项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f6622955739, createdName=12498e67m35暂无昵称, createdTime=Mon Feb 27 12:51:00 CST 2017, time=2017-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=109236, encodeId=4baa109236eb, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 23:51:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=108784, encodeId=1d78108e84df, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 09:39:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106531, encodeId=f91e106531f1, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Aug 29 05:17:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286362, encodeId=caee1286362ac, content=<a href='/topic/show?id=24395268347' target=_blank style='color:#2F92EE;'>#性激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52683, encryptionId=24395268347, topicName=性激素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Mon Aug 29 03:51:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106456, encodeId=a3c0106456e9, content=学习了,慢慢消化, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160616/IMG5762A3665DC7B3997.jpg, createdBy=df0a1649089, createdName=ys2323, createdTime=Sun Aug 28 22:38:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106033, encodeId=1c081060334d, content=很全面,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sun Aug 28 01:15:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106010, encodeId=c18f10601032, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 27 23:31:00 CST 2016, time=2016-08-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=206964, encodeId=d74420696435, content=很详细,又明白。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e5d2054796, createdName=1591ec95f6m, createdTime=Mon Jun 05 22:02:46 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182675, encodeId=a74e1826e582, content=很实用,请问达芙通对性激素的结果影响大吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e9a1831510, createdName=ms1301173364092757, createdTime=Sat Mar 25 19:10:09 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642531, encodeId=f0ad164253127, content=<a href='/topic/show?id=d13f526846e' target=_blank style='color:#2F92EE;'>#性激素六项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52684, encryptionId=d13f526846e, topicName=性激素六项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f6622955739, createdName=12498e67m35暂无昵称, createdTime=Mon Feb 27 12:51:00 CST 2017, time=2017-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=109236, encodeId=4baa109236eb, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 23:51:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=108784, encodeId=1d78108e84df, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 09:39:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106531, encodeId=f91e106531f1, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Aug 29 05:17:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286362, encodeId=caee1286362ac, content=<a href='/topic/show?id=24395268347' target=_blank style='color:#2F92EE;'>#性激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52683, encryptionId=24395268347, topicName=性激素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Mon Aug 29 03:51:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106456, encodeId=a3c0106456e9, content=学习了,慢慢消化, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160616/IMG5762A3665DC7B3997.jpg, createdBy=df0a1649089, createdName=ys2323, createdTime=Sun Aug 28 22:38:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106033, encodeId=1c081060334d, content=很全面,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sun Aug 28 01:15:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106010, encodeId=c18f10601032, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 27 23:31:00 CST 2016, time=2016-08-27, status=1, ipAttribution=)]
    2016-09-01 李东泽

    很好,不错,以后会多学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=206964, encodeId=d74420696435, content=很详细,又明白。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e5d2054796, createdName=1591ec95f6m, createdTime=Mon Jun 05 22:02:46 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182675, encodeId=a74e1826e582, content=很实用,请问达芙通对性激素的结果影响大吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e9a1831510, createdName=ms1301173364092757, createdTime=Sat Mar 25 19:10:09 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642531, encodeId=f0ad164253127, content=<a href='/topic/show?id=d13f526846e' target=_blank style='color:#2F92EE;'>#性激素六项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52684, encryptionId=d13f526846e, topicName=性激素六项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f6622955739, createdName=12498e67m35暂无昵称, createdTime=Mon Feb 27 12:51:00 CST 2017, time=2017-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=109236, encodeId=4baa109236eb, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 23:51:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=108784, encodeId=1d78108e84df, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 09:39:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106531, encodeId=f91e106531f1, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Aug 29 05:17:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286362, encodeId=caee1286362ac, content=<a href='/topic/show?id=24395268347' target=_blank style='color:#2F92EE;'>#性激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52683, encryptionId=24395268347, topicName=性激素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Mon Aug 29 03:51:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106456, encodeId=a3c0106456e9, content=学习了,慢慢消化, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160616/IMG5762A3665DC7B3997.jpg, createdBy=df0a1649089, createdName=ys2323, createdTime=Sun Aug 28 22:38:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106033, encodeId=1c081060334d, content=很全面,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sun Aug 28 01:15:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106010, encodeId=c18f10601032, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 27 23:31:00 CST 2016, time=2016-08-27, status=1, ipAttribution=)]
    2016-09-01 李东泽

    很好,不错,以后会多学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=206964, encodeId=d74420696435, content=很详细,又明白。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e5d2054796, createdName=1591ec95f6m, createdTime=Mon Jun 05 22:02:46 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182675, encodeId=a74e1826e582, content=很实用,请问达芙通对性激素的结果影响大吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e9a1831510, createdName=ms1301173364092757, createdTime=Sat Mar 25 19:10:09 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642531, encodeId=f0ad164253127, content=<a href='/topic/show?id=d13f526846e' target=_blank style='color:#2F92EE;'>#性激素六项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52684, encryptionId=d13f526846e, topicName=性激素六项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f6622955739, createdName=12498e67m35暂无昵称, createdTime=Mon Feb 27 12:51:00 CST 2017, time=2017-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=109236, encodeId=4baa109236eb, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 23:51:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=108784, encodeId=1d78108e84df, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 09:39:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106531, encodeId=f91e106531f1, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Aug 29 05:17:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286362, encodeId=caee1286362ac, content=<a href='/topic/show?id=24395268347' target=_blank style='color:#2F92EE;'>#性激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52683, encryptionId=24395268347, topicName=性激素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Mon Aug 29 03:51:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106456, encodeId=a3c0106456e9, content=学习了,慢慢消化, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160616/IMG5762A3665DC7B3997.jpg, createdBy=df0a1649089, createdName=ys2323, createdTime=Sun Aug 28 22:38:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106033, encodeId=1c081060334d, content=很全面,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sun Aug 28 01:15:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106010, encodeId=c18f10601032, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 27 23:31:00 CST 2016, time=2016-08-27, status=1, ipAttribution=)]
    2016-08-29 忠诚向上

    好好学习一下

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=206964, encodeId=d74420696435, content=很详细,又明白。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e5d2054796, createdName=1591ec95f6m, createdTime=Mon Jun 05 22:02:46 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182675, encodeId=a74e1826e582, content=很实用,请问达芙通对性激素的结果影响大吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e9a1831510, createdName=ms1301173364092757, createdTime=Sat Mar 25 19:10:09 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642531, encodeId=f0ad164253127, content=<a href='/topic/show?id=d13f526846e' target=_blank style='color:#2F92EE;'>#性激素六项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52684, encryptionId=d13f526846e, topicName=性激素六项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f6622955739, createdName=12498e67m35暂无昵称, createdTime=Mon Feb 27 12:51:00 CST 2017, time=2017-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=109236, encodeId=4baa109236eb, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 23:51:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=108784, encodeId=1d78108e84df, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 09:39:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106531, encodeId=f91e106531f1, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Aug 29 05:17:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286362, encodeId=caee1286362ac, content=<a href='/topic/show?id=24395268347' target=_blank style='color:#2F92EE;'>#性激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52683, encryptionId=24395268347, topicName=性激素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Mon Aug 29 03:51:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106456, encodeId=a3c0106456e9, content=学习了,慢慢消化, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160616/IMG5762A3665DC7B3997.jpg, createdBy=df0a1649089, createdName=ys2323, createdTime=Sun Aug 28 22:38:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106033, encodeId=1c081060334d, content=很全面,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sun Aug 28 01:15:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106010, encodeId=c18f10601032, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 27 23:31:00 CST 2016, time=2016-08-27, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=206964, encodeId=d74420696435, content=很详细,又明白。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e5d2054796, createdName=1591ec95f6m, createdTime=Mon Jun 05 22:02:46 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182675, encodeId=a74e1826e582, content=很实用,请问达芙通对性激素的结果影响大吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e9a1831510, createdName=ms1301173364092757, createdTime=Sat Mar 25 19:10:09 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642531, encodeId=f0ad164253127, content=<a href='/topic/show?id=d13f526846e' target=_blank style='color:#2F92EE;'>#性激素六项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52684, encryptionId=d13f526846e, topicName=性激素六项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f6622955739, createdName=12498e67m35暂无昵称, createdTime=Mon Feb 27 12:51:00 CST 2017, time=2017-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=109236, encodeId=4baa109236eb, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 23:51:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=108784, encodeId=1d78108e84df, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 09:39:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106531, encodeId=f91e106531f1, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Aug 29 05:17:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286362, encodeId=caee1286362ac, content=<a href='/topic/show?id=24395268347' target=_blank style='color:#2F92EE;'>#性激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52683, encryptionId=24395268347, topicName=性激素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Mon Aug 29 03:51:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106456, encodeId=a3c0106456e9, content=学习了,慢慢消化, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160616/IMG5762A3665DC7B3997.jpg, createdBy=df0a1649089, createdName=ys2323, createdTime=Sun Aug 28 22:38:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106033, encodeId=1c081060334d, content=很全面,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sun Aug 28 01:15:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106010, encodeId=c18f10601032, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 27 23:31:00 CST 2016, time=2016-08-27, status=1, ipAttribution=)]
    2016-08-28 ys2323

    学习了,慢慢消化

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=206964, encodeId=d74420696435, content=很详细,又明白。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e5d2054796, createdName=1591ec95f6m, createdTime=Mon Jun 05 22:02:46 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182675, encodeId=a74e1826e582, content=很实用,请问达芙通对性激素的结果影响大吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e9a1831510, createdName=ms1301173364092757, createdTime=Sat Mar 25 19:10:09 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642531, encodeId=f0ad164253127, content=<a href='/topic/show?id=d13f526846e' target=_blank style='color:#2F92EE;'>#性激素六项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52684, encryptionId=d13f526846e, topicName=性激素六项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f6622955739, createdName=12498e67m35暂无昵称, createdTime=Mon Feb 27 12:51:00 CST 2017, time=2017-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=109236, encodeId=4baa109236eb, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 23:51:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=108784, encodeId=1d78108e84df, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 09:39:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106531, encodeId=f91e106531f1, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Aug 29 05:17:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286362, encodeId=caee1286362ac, content=<a href='/topic/show?id=24395268347' target=_blank style='color:#2F92EE;'>#性激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52683, encryptionId=24395268347, topicName=性激素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Mon Aug 29 03:51:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106456, encodeId=a3c0106456e9, content=学习了,慢慢消化, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160616/IMG5762A3665DC7B3997.jpg, createdBy=df0a1649089, createdName=ys2323, createdTime=Sun Aug 28 22:38:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106033, encodeId=1c081060334d, content=很全面,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sun Aug 28 01:15:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106010, encodeId=c18f10601032, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 27 23:31:00 CST 2016, time=2016-08-27, status=1, ipAttribution=)]
    2016-08-28 1e0ece0dm09(暂无匿称)

    很全面,谢谢分享

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=206964, encodeId=d74420696435, content=很详细,又明白。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e5d2054796, createdName=1591ec95f6m, createdTime=Mon Jun 05 22:02:46 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182675, encodeId=a74e1826e582, content=很实用,请问达芙通对性激素的结果影响大吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e9a1831510, createdName=ms1301173364092757, createdTime=Sat Mar 25 19:10:09 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642531, encodeId=f0ad164253127, content=<a href='/topic/show?id=d13f526846e' target=_blank style='color:#2F92EE;'>#性激素六项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52684, encryptionId=d13f526846e, topicName=性激素六项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f6622955739, createdName=12498e67m35暂无昵称, createdTime=Mon Feb 27 12:51:00 CST 2017, time=2017-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=109236, encodeId=4baa109236eb, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 23:51:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=108784, encodeId=1d78108e84df, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 09:39:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106531, encodeId=f91e106531f1, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Aug 29 05:17:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286362, encodeId=caee1286362ac, content=<a href='/topic/show?id=24395268347' target=_blank style='color:#2F92EE;'>#性激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52683, encryptionId=24395268347, topicName=性激素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Mon Aug 29 03:51:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106456, encodeId=a3c0106456e9, content=学习了,慢慢消化, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160616/IMG5762A3665DC7B3997.jpg, createdBy=df0a1649089, createdName=ys2323, createdTime=Sun Aug 28 22:38:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106033, encodeId=1c081060334d, content=很全面,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sun Aug 28 01:15:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106010, encodeId=c18f10601032, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 27 23:31:00 CST 2016, time=2016-08-27, status=1, ipAttribution=)]
    2016-08-27 doctorJiangchao

    继续学习

    0

相关资讯

JCEM:绝经后女性体内内源性性激素与脂肪因子、胃饥饿素的关联研究

研究背景: 有研究提示性激素、脂肪因子及胃饥饿素在控制食欲、能量平衡、维持脂肪量和炎症等方面处于中心位置。女性在绝经后有体重增加的趋势,并且脂肪组织是绝经后主要的性激素来源。而女性绝经后患心血管疾病的风险显著增加,所以理解这些物质的动态变化具有重要意义。 研究目的: 评估绝经后女性体内脂肪因子及胃饥饿素与性激素水平的相关性。 研究设计: 交叉横断面研究。 研究依

Cell Res:新研究表明预防乳腺癌有戏

大约8名女性中就有一人将在她的一生当中患上浸润性乳腺癌。这可能是使用人工合成性激素和其他环境因子导致的,也可能是BRCA1基因等发生突变导致的。平均而言,BRCA1基因发生突变的女性有高达87%的风险患上乳腺癌。截至目前,预防性手术切除是显著降低乳腺癌风险的唯一方法,但是这也经常伴随着术后并发症。2010年,奥地利科学院分子生物技术研究所(IMBA)科学主任Josef Penninger和他的

性激素与老年女性慢性骨骼肌肉痛相关

根据最近在线发表于《疼痛》杂志上的一项荷兰研究,性激素水平降低与社区老年女性慢性肌肉骨骼痛风险增加相关。 研究人员表示,相较于男性,慢性疼痛在女性人群中更加普遍。而且这种差异会随着年龄增加而变大。尤其对女性而言,随时间推移性激素的变化可影响疼痛敏感性。 为进一步探究性激素与慢性疼痛的相关性,研究人员对超过5500名女性和超过4200名男性数据进行分析(平均年龄,

Clin Endocrinol:性激素结合球蛋白与血糖和血脂水平相关

性激素结合球蛋白(SHBG)和肝酶水平都与2型糖尿病风险有关。然而,SHBG与肝酶和肝内脂肪含量之间的关系仍不清楚。为了探讨SHBG是否与血糖和血脂水平有关,以及这种相关性是否依赖肝脂肪含量、肝酶或性激素浓度,来自法国雷恩大学Fabrice Bonnet教授及其团队进行了一项研究,该研究发现代谢紊乱男性SHBG与空腹血糖、HbA1c和血脂水平显著相关,肝内脂肪可能涉及SHBG与血糖和血脂代谢之间的

PLoS One:揭开性激素与基因组表达的神秘联系

目前有来自流行病学和临床研究的多方证据观察表明,人体内性激素水平与各种代谢疾病或其危险因素密切相关,但是目前关于两者间联系的病理生理学解释依旧一片空白,究竟是什么机制让性激素影响了人体代谢,造成了代谢疾病的风险增加。近期Haring R等研究者进行了一项研究,从性激素与全血基因表达情况着手,分析性激素水平和全血基因表达的联系,拟以从基因转录水平试图揭开该神秘面试。。该研究数据全部来自于波美拉尼亚地

Baidu
map
Baidu
map
Baidu
map